The global oral biologics and biosimilars market reached a value of nearly $3,076.1 million in 2019, having grown at a compound annual growth rate (CAGR) of 6.5% since 2015, and is expected to grow at a CAGR of 17.1% to nearly $5,787.9 million by 2023. Also, the market is expected to growth to $8,687.7 million in 2025 at a CAGR of 22.5% and to $23,585.5 million in 2030 at a CAGR of 22.1%.
Request For The Sample Of The Oral Biologics And Biosimilars Market Here:
The oral biologics and biosimilars market consist of sales of oral biologics and biosimilar products and related services used to treat chronic diseases such as diabetes, arthritis, and cancer.
Place A Direct Purchase Order Of The Oral Biologics And Biosimilars Report Here:
The oral biologics and biosimilars market report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Some of the major players of the oral biologics and biosimilars market are Merck & Co, GlaxoSmithKline, Novo Nordisk, ALK-Abello A/S, Aimmune Therapeutics, Inc.
The oral biologics & biosimilars market is segmented by therapeutic mechanism, disease, molecule type, distribution channel and by geography.?
By Therapeutic Mechanism – The oral biologics & biosimilars market can be segmented by therapeutic mechanism
- a. Tumor Necrosis Factor-Alpha Inhibitors
- b. Lymphocyte Modulators
- c. Interleukin Inhibitors
- d. GPCR (insulin, growth hormone, parathyroid hormone) Modulators
- e. Immunostimulants
- f. Others
By Disease –? The oral biologics & biosimilars market can be segmented by disease
- a. Diabetes
- b. Arthritis & Chron`s Disease
- c. Cancer
- d. Infectious Diseases
- e. Other Autoimmune Diseases
- f. Others Diseases
By Molecule Type –? The Oral Biologics & Biosimilars market can be segmented by molecule
- a. Vaccines
- b. Proteins & Peptides
- c. Monoclonal Antibodies
- d. Others
By Distribution Channel–? The oral biologics & biosimilars market can be segmented by distribution channel
- a. Hospital Pharmacies
- b. Retail Pharmacies
- c. Online Pharmacies
Read More On The Global Oral Biologics And Biosimilars Market Report:
The oral biologics and biosimilars market report describes and explains the global oral biologics and biosimilars market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The oral biologics and biosimilars report evaluates the market across each region and for the major economies within each region.
The countries covered in the global oral biologics and biosimilars market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.
The regions covered in the global oral biologics and biosimilars market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Full Report Includes
- Executive Summary
- Report Structure
- Oral Biologics And Biosimilars Market Characteristics
- Oral Biologics And Biosimilars Market Product Analysis
- Oral Biologics And Biosimilars Market Supply Chain
- Key Mergers And Acquisitions In The Oral Biologics And Biosimilars Market
- Market Background: Machinery Manufacturing Market
- Copyright And Disclaimer
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model